GALIMBERTI STEFANIA

Ruolo: 
Professore ordinario
Settore scientifico disciplinare: 
STATISTICA MEDICA (MED/01)
Telefono: 
0264488164

Pubblicazioni

  • Soria, A., Galimberti, S., Lapadula, G., Visco, F., Ardini, A., Valsecchi, M., et al. (2021). The high volume of patients admitted during the SARS-CoV-2 pandemic has an independent harmful impact on in-hospital mortality from COVID-19. PLOS ONE, 16(1 (January 2021)). Dettaglio
  • Canini, V., Bono, F., Calzavacca, P., Capitoli, G., Foti, G., Fraggetta, F., et al. (2021). Cytopathology of Bronchoalveolar Lavages in COVID-19 Pneumonia: A Pilot Study. CANCER CYTOPATHOLOGY [10.1002/cncy.22422]. Dettaglio
  • Zeppellini, A., Galimberti, S., Leone, B., Pacifico, C., Riva, F., Cicchiello, F., et al. (2021). Comparison of tumor microenvironment in primary and paired metastatic ER+/HER2- breast cancers: results of a pilot study. BMC CANCER, 21(1), 260-270 [10.1186/s12885-021-07960-z]. Dettaglio
  • Leni, D., Seminati, D., Fior, D., Vacirca, F., Capitoli, G., Cazzaniga, L., et al. (2021). Diagnostic performances of the acr-tirads system in thyroid nodules triage: A prospective single center study. CANCERS, 13(9 (1 May 2021)). Dettaglio
  • Capici, S., Sala, L., Galimberti, S., Valsecchi, M., Squillace, N., Gustinetti, G., et al. (2021). The role for tocilizumab in covid-19 patients: Reflections on monza cohort data. INFECTION AND DRUG RESISTANCE, 14, 1389-1392. Dettaglio